Clinical Trials Logo

Central Nervous System Diseases clinical trials

View clinical trials related to Central Nervous System Diseases.

Filter by:

NCT ID: NCT05963828 Recruiting - Stroke Clinical Trials

Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network

COMPLIANCE-MT
Start date: August 8, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of social network in improving drug compliance and risk factors control rate of stroke high-risk population after discharge.

NCT ID: NCT05903235 Not yet recruiting - Stroke Clinical Trials

Mixed Reality and Virtual Reality Technology With Mirror Therapy for Stroke Rehabilitation

Start date: March 2024
Phase: N/A
Study type: Interventional

The specific study aims will be: 1. To design and develop the hardware and software of the VR+MT and MR+MT systems. 2. To test the feasibility of the VR+MT and MR+MT systems from the patients and to collect the feedback of users with respect to their experiences. 3. To examine the treatment effects of VR+MT and MR+MT compared to the traditional MT (i.e., control group) in patients with stroke by conducting a randomized controlled trial. 4. To identify who will be the possible good responders to VR+MT and MR+MT based on their baseline motor functions and mental imagery abilities.

NCT ID: NCT05892510 Not yet recruiting - Clinical trials for Cerebrovascular Disorders

Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke

Start date: September 1, 2023
Phase: Phase 2/Phase 3
Study type: Interventional

Multicentre, prospective, Multi-arm Multi-stage (MAMS) seamless phase 2b/3 interventional randomized placebo-controlled double-blinded parallel-assignment (2 arms with 1:1 randomization) efficacy and safety trial to test intra-arterial tenecteplase at the completion of thrombectomy versus best practice in participants with anterior circulation LVO receiving mechanical thrombectomy within 24 hours of symptoms onset.

NCT ID: NCT05886114 Recruiting - Alzheimer Disease Clinical Trials

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

HERITAGE
Start date: May 28, 2023
Phase: N/A
Study type: Interventional

A study conducted in Finland discovered that a multidomain intervention, consisting of physical activity, nutritional guidance, cognitive training, social activities, and management of vascular risk factors, effectively decelerated cognitive decline in healthy older adults who were at an increased risk of cognitive decline. The HERITAGE study is a 2-year clustered randomized controlled trial (clustered-RCT) that explores the efficacy of a multidomain intervention among 1200 elderly residents with a higher risk of cognitive decline and dementia in Zhejiang Province, China

NCT ID: NCT05852379 Not yet recruiting - Clinical trials for Spinal Cord Injuries

Transcutaneous Auricular Vagus Nerve Stimulation in Spinal Cord Injury

taVNS
Start date: July 1, 2023
Phase: N/A
Study type: Interventional

This study is a single blinded prospective randomized monocentric study examining the effectiveness of transcutaneous auricular vagus nerve stimulation paired with rehabilitation and low frequency/antidromic stimulation of the pelvic somatic nerves. The investigator hypothesize that treatment using transcutaneous auricular vagus nerve stimulation will improve gait recovery in spinal cord injured participants already treating by rehabilitation and pelvic nerves neuromodulation.

NCT ID: NCT05815836 Completed - Stroke Clinical Trials

Precision Medicine in Stroke

PROMISE
Start date: October 2013
Phase:
Study type: Observational

PROMISE aims at identifying novel diagnostic and prognostic circulating biomarkers for patients with acute stroke and at informing on crucial yet undetected pathophysiological mechanisms driving outcome after stroke by enriching all phenotypic information available from clinical routine with in-depth quantification of the circulating proteome and metabolome as well as other entities.

NCT ID: NCT05778279 Recruiting - Clinical trials for Central Nervous System Diseases

Role of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies

Start date: September 30, 2024
Phase:
Study type: Observational

The fetal CNS screening examination during the mid-trimester scan in low-risk pregnancies should include evaluation of the fetal head and spine, using transabdominal sonography. Evaluation of two axial planes allows visualization of the relevant cerebral structures to assess the anatomic integrity of the fetal brain.These planes are commonly referred to as the transventricular and transcerebellar planes. A third plane, the so-called transthalamic plane, is frequently added, mostly for the purpose of biometry. Structures that should be noted in the routine examination include the lateral ventricles, the cerebellum, the cisterna magna, and the cavum septi pellucidi (CSP). Head shape and brain texture should also be noted on these views.

NCT ID: NCT05771922 Recruiting - Clinical trials for Ultrasound Therapy; Complications Anomaly Central Nervous System Diseases

Implication of New High Resolution Ultrasonographic Modalities for Diagnosis of Fetal Nervous System Anomalies

Start date: November 30, 2024
Phase:
Study type: Observational

The fetal CNS screening examination during the mid-trimester scan in low-risk pregnancies should include evaluation of the fetal head and spine, using transabdominal sonography. Evaluation of two axial planes allows visualization of the relevant cerebral structures to assess the anatomic integrity of the fetal brain.These planes are commonly referred to as the transventricular and transcerebellar planes. A third plane, the so-called transthalamic plane, is frequently added, mostly for the purpose of biometry. Structures that should be noted in the routine examination include the lateral ventricles, the cerebellum, the cisterna magna, and the cavum septi pellucidi (CSP). Head shape and brain texture should also be noted on these views.

NCT ID: NCT05738486 Recruiting - Dementia Clinical Trials

A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)

Start date: February 28, 2023
Phase: Phase 3
Study type: Interventional

This study will investigate different donanemab dosing regimens and their effect on the frequency and severity of ARIA-E in adults with early symptomatic Alzheimer's disease (AD) and explore participant characteristics that might predict risk of ARIA.

NCT ID: NCT05737420 Active, not recruiting - Stroke Clinical Trials

Video-call Assisted Assessment of Acute Stroke in Addition to Stroke Severity Scales in a Prehospital Setting

Start date: July 6, 2023
Phase: N/A
Study type: Interventional

This study aims to investigate whether a live stream video between the on-call neurologist and the emergency medical services is feasible.